BR0013416A - Droga, uso de uma droga selecionada do grupo que consiste de pelo menos um bisfosfonato, e, método para tratamento de um osso fraturado - Google Patents
Droga, uso de uma droga selecionada do grupo que consiste de pelo menos um bisfosfonato, e, método para tratamento de um osso fraturadoInfo
- Publication number
- BR0013416A BR0013416A BR0013416-3A BR0013416A BR0013416A BR 0013416 A BR0013416 A BR 0013416A BR 0013416 A BR0013416 A BR 0013416A BR 0013416 A BR0013416 A BR 0013416A
- Authority
- BR
- Brazil
- Prior art keywords
- drug
- group
- bisphosphonate
- treating
- fractured bone
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
- A61K31/6615—Compounds having two or more esterified phosphorus acid groups, e.g. inositol triphosphate, phytic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
- A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
- A61K49/0008—Screening agents using (non-human) animal models or transgenic animal models or chimeric hosts, e.g. Alzheimer disease animal model, transgenic model for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physical Education & Sports Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pathology (AREA)
- Rheumatology (AREA)
- Toxicology (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
"DROGA, USO DE UMA DROGA SELECIONADA DO GRUPO QUE CONSISTE DE PELO MENOS UM BISFOSFONATO, E, MéTODO PARA TRATAMENTO DE UM OSSO FRATURADO". Um droga selecionada de um grupo que consiste de bisfosfonatos para promover o crescimento de osso e para o tratamento de uma fratura.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPQ2325A AUPQ232599A0 (en) | 1999-08-19 | 1999-08-19 | Drug for treating fractures |
PCT/AU2000/000982 WO2001013922A1 (en) | 1999-08-19 | 2000-08-17 | Drug for treating fractures |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0013416A true BR0013416A (pt) | 2002-04-30 |
Family
ID=3816500
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0013416-3A BR0013416A (pt) | 1999-08-19 | 2000-08-17 | Droga, uso de uma droga selecionada do grupo que consiste de pelo menos um bisfosfonato, e, método para tratamento de um osso fraturado |
Country Status (16)
Country | Link |
---|---|
EP (1) | EP1214079A4 (pt) |
JP (1) | JP2003507426A (pt) |
KR (1) | KR20020027562A (pt) |
CN (1) | CN100345548C (pt) |
AU (1) | AUPQ232599A0 (pt) |
BR (1) | BR0013416A (pt) |
CA (1) | CA2381302A1 (pt) |
HK (1) | HK1048441B (pt) |
HU (1) | HUP0202396A3 (pt) |
IL (1) | IL148166A0 (pt) |
NO (1) | NO20020784D0 (pt) |
NZ (1) | NZ517538A (pt) |
PL (1) | PL353485A1 (pt) |
SK (1) | SK2382002A3 (pt) |
WO (1) | WO2001013922A1 (pt) |
ZA (1) | ZA200202160B (pt) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2004527479A (ja) | 2001-02-06 | 2004-09-09 | ザ ロイヤル アレクサンドラ ホスピタル フォー チルドレン | 骨壊死の治療用および骨壊死の発症のリスクのある患者のマネージメント用医薬 |
WO2002080933A1 (en) * | 2001-04-03 | 2002-10-17 | The Royal Alexandra Hospital For Children | A drug for use in bone grafting |
AUPR553701A0 (en) * | 2001-06-07 | 2001-07-12 | Royal Alexandra Hospital For Children, The | A device for the delivery of a drug to a fractured bone |
EP1508343B1 (en) * | 2003-08-21 | 2015-11-04 | AddBIO AB | Bisphosponate coated implant device and method therefor |
MXPA06003063A (es) * | 2003-09-19 | 2006-05-31 | Pfizer Prod Inc | Composiciones farmaceuticas y metodos que comprenden combinaciones de derivados de 2-alquiliden-19-nor-vitamina- d y un bisfosfonato. |
ITMI20040218A1 (it) * | 2004-02-10 | 2004-05-10 | Abiogen Pharma Spa | Uso di neridronato sodico per promuovere la neoformazione ossea |
ITMI20040641A1 (it) * | 2004-03-31 | 2004-06-30 | Tb Technology S R L | Composizioni bioadesive bifunzionali per implantologia orale |
AR048742A1 (es) * | 2004-12-22 | 2006-05-24 | Gador Sa | Sistema de aplicacion de medicamentos intra-oral |
WO2007048264A1 (de) * | 2005-10-27 | 2007-05-03 | Thommen Medical Ag | Dentalimplantat und verfahren zu dessen herstellung |
US8882740B2 (en) | 2009-12-23 | 2014-11-11 | Stryker Trauma Gmbh | Method of delivering a biphosphonate and/or strontium ranelate below the surface of a bone |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR8107560A (pt) * | 1981-11-19 | 1983-07-05 | Luiz Romariz Duarte | Estimulacao ultra-sonica da consolidacao de fraturas osseas |
CA2124792C (en) * | 1991-12-17 | 2000-07-04 | Ann D. Geddes | Methods for the treatment of osteoporosis using bisphosphonates and parathyroid hormone |
AU670337B2 (en) * | 1992-11-30 | 1996-07-11 | Novartis Ag | Use of certain methanebisphosphonic acid derivatives in fracture healing |
EP0600834A1 (en) * | 1992-11-30 | 1994-06-08 | Ciba-Geigy Ag | Use of methanebisphosphonic acid derivatives for the manufacture of a medicament for fracture healing |
WO1994014455A1 (en) * | 1992-12-23 | 1994-07-07 | Merck & Co., Inc. | Bisphosphonate/estrogen therapy for treating and preventing bone loss |
US5403829A (en) * | 1993-03-24 | 1995-04-04 | Leiras Oy | Use of bisphosphonates in endo-osteal bone surgery |
US5646134A (en) * | 1994-04-21 | 1997-07-08 | Merck & Co., Inc. | Alendronate therapy to prevent loosening of, or pain associated with, orthopedic implant devices |
GB9408775D0 (en) * | 1994-05-04 | 1994-06-22 | Ciba Geigy Ag | Use of certain methanebisphosphonic acid derivatives to prevent prothesis loosening and prothesis migration |
JPH11506750A (ja) * | 1995-06-06 | 1999-06-15 | メルク エンド カンパニー インコーポレーテッド | 慢性関節リウマチに係わる骨欠損に対するビスホスホネート療法 |
US5616571A (en) * | 1995-06-06 | 1997-04-01 | Merck & Co., Inc. | Bisphosphonates prevent bone loss associated with immunosuppressive therapy |
US5853759A (en) * | 1996-05-17 | 1998-12-29 | Merck & Co.. Inc. | Effervescent alendronate formulation |
GB9613722D0 (en) * | 1996-06-28 | 1996-08-28 | Univ Liverpool | Chemical compounds |
-
1999
- 1999-08-19 AU AUPQ2325A patent/AUPQ232599A0/en not_active Abandoned
-
2000
- 2000-08-17 SK SK238-2002A patent/SK2382002A3/sk not_active Application Discontinuation
- 2000-08-17 EP EP00952791A patent/EP1214079A4/en not_active Withdrawn
- 2000-08-17 CN CNB008117659A patent/CN100345548C/zh not_active Expired - Fee Related
- 2000-08-17 CA CA002381302A patent/CA2381302A1/en not_active Abandoned
- 2000-08-17 HU HU0202396A patent/HUP0202396A3/hu unknown
- 2000-08-17 JP JP2001518059A patent/JP2003507426A/ja active Pending
- 2000-08-17 NZ NZ517538A patent/NZ517538A/en unknown
- 2000-08-17 KR KR1020027002160A patent/KR20020027562A/ko not_active Application Discontinuation
- 2000-08-17 BR BR0013416-3A patent/BR0013416A/pt not_active Application Discontinuation
- 2000-08-17 PL PL00353485A patent/PL353485A1/xx not_active Application Discontinuation
- 2000-08-17 IL IL14816600A patent/IL148166A0/xx unknown
- 2000-08-17 WO PCT/AU2000/000982 patent/WO2001013922A1/en active IP Right Grant
-
2002
- 2002-02-18 NO NO20020784A patent/NO20020784D0/no not_active Application Discontinuation
- 2002-03-15 ZA ZA200202160A patent/ZA200202160B/en unknown
-
2003
- 2003-01-21 HK HK03100502.8A patent/HK1048441B/zh not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
AUPQ232599A0 (en) | 1999-09-09 |
NO20020784L (no) | 2002-02-18 |
NO20020784D0 (no) | 2002-02-18 |
KR20020027562A (ko) | 2002-04-13 |
NZ517538A (en) | 2003-07-25 |
SK2382002A3 (en) | 2002-09-10 |
ZA200202160B (en) | 2003-08-27 |
PL353485A1 (en) | 2003-11-17 |
HUP0202396A2 (hu) | 2002-11-28 |
HK1048441A1 (en) | 2003-04-04 |
CN100345548C (zh) | 2007-10-31 |
IL148166A0 (en) | 2002-09-12 |
HK1048441B (zh) | 2008-02-22 |
JP2003507426A (ja) | 2003-02-25 |
CA2381302A1 (en) | 2001-03-01 |
WO2001013922A1 (en) | 2001-03-01 |
EP1214079A1 (en) | 2002-06-19 |
EP1214079A4 (en) | 2004-03-24 |
HUP0202396A3 (en) | 2005-02-28 |
CN1370071A (zh) | 2002-09-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2138067T3 (es) | Proceso para el tratamiento de un implante quirurgico. | |
BRPI0007487B8 (pt) | difenil-uréias substituídas com w-carbóxi-arilas como inibidores de raf cinase | |
BR0010524A (pt) | Tratamento de tumores humanos refratários com antagonistas de receptor de fator de crescimento epidérmico | |
BR0014767A (pt) | Fibras de sementes de plantas e uso | |
FI971974A0 (fi) | Tienopyridiini- tai tienopyrimidiinijohdannaiset ja niiden käyttö | |
BR0016058A (pt) | Compostos de fosfonato | |
BR0107942A (pt) | Polìmeros de proteìna de liberação lenta | |
BR0113184A (pt) | Implante artificial e processo para produzir o mesmo | |
WO2002041837A3 (en) | Treatment of mucositis | |
MXPA02005173A (es) | Composicion farmaceutica para el tratamiento de enfermedades asociadas con disminucion de masa osea. | |
SE9901272D0 (sv) | New improved formulation | |
AR005987A1 (es) | Terapia combinada para la osteoporosis | |
PT938326E (pt) | Fosfopeptidos de sintese para o tratamento de doencas dos ossos | |
ATE232874T1 (de) | Prostaglandin-konjugate zur behandlung von knochenkrankheiten | |
BR0105457A (pt) | Combinações terapêuticas para estimulação do crescimento ósseo | |
BR9708114A (pt) | Análogos xantona para o tratamento de doenças infecciosas. | |
BR0112350A (pt) | Composto, composição farmacêutica, e, método de tratar um animal afligido por um distúrbio neurológico ou psicológico | |
BR0013416A (pt) | Droga, uso de uma droga selecionada do grupo que consiste de pelo menos um bisfosfonato, e, método para tratamento de um osso fraturado | |
DE60233803D1 (de) | 5-cnac zur oralen verabreichung von parathormonfragmenten | |
BR9813996A (pt) | 2-arilbenzo[b]tiofenos úteis para o tratamento de sìndrome da privação de estrogênio | |
BR0212757A (pt) | Composição, método para produzir uma composição de fator de crescimento, e, método para tratar um defeito de osso, tendão ou cartilagem | |
ATE225171T1 (de) | Aminosäurederivate zur behandlung von schlaganfall | |
BR9811643A (pt) | Suplementação quìmica de osso | |
DE69920015D1 (de) | Verfahren zur induktion der herstellung von wachstumsfaktoren | |
BR0015781A (pt) | Composição farmacêutica para tratamento de doenças associadas à diminuição de massa óssea |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B07B | Technical examination (opinion): publication cancelled [chapter 7.2 patent gazette] |
Free format text: REFERENTE A RPI NO 2011 DE 21/07/2009. |
|
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8, 11, 13, 10(VIII), 24 E 25 DA LPI |
|
B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL. |